2020-07-30T10:30:01+00:00

EU secures 30,000 doses of Covid-19 drug

Remdesivir Credit: Dimitri Karastelev

Despite uncertainties in the effectiveness of treatment with Remdesivir, the European Commission has secured from US-based Gilead 30,000 doses on a €63 million contract.
Remdesivir is the first drug to be approved in the European Union for the treatment of Covid-19.

Sources: Content Sources

Source: dpa-international.com

Image Source

Dimitri Karastelev

Pentributor:

Lino M.S. Rodrigues

@LINO_MSR

Software therapist 👨🏽‍🔧 Human experience optimizer 🦸🏽 Guardian of the galaxy

Card reviewed by: @ericof

Categorization: Locations & Places

European Union

Organizations & Institutions

Gilead Sciences

Cookies🍪

Our website uses scripts, such as cookies, to technically provide the site ("essential scripts") and third-party website tracking technologies to provide and continually improve our services and display advertisements based on the perceived interests of users. By clicking the "Accept All" button, the website visitor agrees to the activation of all scripts. Essential cookies are also executed without the consent. The consent can be revoked or changed at any time with effect for the future. By clicking the "Reject" button, only essential cookies are used. In our data protection policy, we provide detailed information about the type and scope of data processing.

Accept All Reject